山东大学耳鼻喉眼学报

• 论文 •    下一篇

COX-2、PCNA及p53在鼻咽癌中的表达及意义

苗北平1, 卢永田1, 许安廷2   

  1. 1. 深圳市第二人民医院耳鼻咽喉-头颈外科, 广东 深圳 518035;2. 山东大学齐鲁医院耳鼻咽喉-头颈外科, 山东 济南 250012
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2007-06-24 发布日期:2007-06-24
  • 通讯作者: 苗北平

Prognostic significance of COX-2,PCNA and p53 in nasopharyngeal carcinoma

MIAO Bei-ping1, LU Yong-tian1, XU An-ting2   

  1. Department of Otolaryngology and Head & Neck Surgery, 1. Shenzhen Second People′s Hospital,Shenzhen 518035, Guangdong, China; 2. Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Received:1900-01-01 Revised:1900-01-01 Online:2007-06-24 Published:2007-06-24
  • Contact: MIAO Bei-ping

摘要: 目的:研究COX-2、PCNA及p53的基因产物在鼻咽癌组织中的表达及与其生物学行为和生存率之间的关系。方法:采用免疫组化SP法检测60例鼻咽癌及30例正常鼻咽组织中COX-2、PCNA 及p53的蛋白表达水平。结果:(1) 鼻咽癌组织COX-2、PCNA 及p53阳性表达率分别为90%、75%和68% ,明显高于正常鼻咽组织;(2) 鼻咽癌组织COX-2、PCNA及p53的表达与临床分期、分化程度和淋巴结转移相关(P<0.05);(3) COX-2、PCNA及p53的表达密切相关;(4) 鼻咽癌组织COX-2、PCNA 阳性表达和生存率呈负相关,是鼻咽癌复发的显著预后因素。结论:鼻咽癌组织中COX-2、PCNA表达水平明显上调,与鼻咽癌的发生发展及预后不良有关,免疫组化检测COX-2、PCNA表达可用以判断鼻咽癌患者的预后。

关键词: 环氧合酶-2, 增殖细胞核抗原, 蛋白, p53, 鼻咽癌, 免疫组化, 预后

Abstract: Objective: To ascertain the possible roles of COX-2,PCNA and p53 in the tumorigenesis and development of nasopharyngeal carcinoma, and to evalulate their impact on the prognosis of nasopharyngeal carcinoma. Methods: Immunohistochemical assay was used to determine COX-2, PCNA and p53 in all specimens, including 60 cases of nasopharyngeal carcinoma and 30 cases of normal nasopharynx. Results: (1) The overall positive expression rate of COX-2, PCNA and p53 in nasopharyngeal carcinoma was 90%, 75% and 68% respectively, higher than that in the normal nasopharynx. (2) Intensity of expression of COX-2, PCNA and p53 in nasopharyngeal carcinoma was related to tumor stage, tumor differentiation and lymph node metastasis (P<0.05). (3) Expressions of COX-2, PCNA and p53 were correlated with each other in nasopharyngeal carcinoma. (4) Positive COX-2 and PCNA were associated with a lower 5-year survival and they were significant prognostic variables for recurrence(P<0.05). Conclusion: COX-2, PCNA and p53 may play vital roles in the tumorigenesis and development of the cancer via different methods. Unfavorable prognosis was associated with expression of COX-2 and PCNA while not with p53. Immunohistochemical assessment of COX-2 and PCNA might be a useful molecular marker for predicting prognosis in nasopharyngeal cancer.

Key words: Cyclooxygenase-2, Proliferating cell nuclear antigen, Protein, p53, Nasopharyngeal carcinoma, Immunohistochemistry, Prognosis

中图分类号: 

  • R739.63
[1] 李梦欣,徐慧,张晓玲,薛晴,纪霜钰,李莹莹,崔丽梅,郭兆剑,宋西成,孙岩,陈良. 糖皮质激素通过下调水通道蛋白2缓解精氨酸加压素诱导的膜迷路积水[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 1-6.
[2] 林小雪,林葆睿,李佩珊,卢标清. 电子鼻咽镜联合窄带成像技术在鼻咽癌中医辨证中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 40-46.
[3] 刘佳珲,田汝宪,李玉梅,宋西成. 构建铜死亡相关lncRNA模型评估头颈鳞状细胞癌预后[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 49-64.
[4] 王暖,王欣阳,吉长皓,刘敏,高建刚,孙锦. 邻近标记技术对活体小鼠耳蜗毛细胞表面蛋白进行特异性标记[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 6-12.
[5] 缪红利,张妍春,郝琳娜,唐乐,何英楠. 活动性眼弓形虫病临床特征及预后分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 82-89.
[6] 彭中华,陈竹,袁洛花,余绍兰,马玉玲. 原发性鼻腔高级别非肠型腺癌1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 95-98.
[7] 段思妤,薛金梅. 组蛋白去乙酰化酶2在慢性气道炎症性疾病糖皮质激素抵抗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 120-126.
[8] 孙凡敏,张娟美,高杰,赵军. 近视中Shh、PI3K/AKT、MMP-2通路及关联性研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 142-148.
[9] 李赞,卢奇,申卫东,侯昭晖,吴南. 坏死性外耳道炎临床诊治18例[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 17-22.
[10] 唐茜,黄茂凌,张吉强,钟诚. 不同发育时期小鼠初级听觉皮层中芳香化酶及雌激素受体表达与听力的相关性[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 46-53.
[11] 刘玉柱,陈尧,苑铁君,李春森,李波. 喉纤维肉瘤1例并相关文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 133-137.
[12] 尹振乾,皇甫辉. 头颈部木村病1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 104-107.
[13] 王盛,李银丹,杨金姬. microRNA在鼻咽癌中的作用及其研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 125-131.
[14] 邱前辉,肖旭平,杨钦泰,叶菁,邓泽义,王德生,谭国林,蒋卫红,卢永田,唐隽,石照辉,邓晓聪,刘遗斌,王跃武,段传志,杜德坤,白小欣,陈文伙,莫立根,蔡楚伟,曾鹏,何旭英,杨一梅,赵洲洋,陈健龙,赵充,林志雄,李先明,李曙平,陈冬平,陈勇,黄莹,陈春燕,韩非,黄理金,瞿申红. 鼻咽癌治疗后并发颈动脉爆裂综合征的临床处理专家共识[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 1-18.
[15] 王思权,朱洪申,张晓斌,赵洲洋,马跃,杨一梅,黄理金. 放射治疗后鼻咽癌患者单侧颈内动脉栓塞术后脑卒中及颅神经麻痹的相关因素分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 19-25.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!